Ledger.Open graph →
SEC Form D · Amendment · filed January 14, 2019

Mirata Pharmaceuticals, LLC

Offering
$8.0M
Sold
$7.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PLYMOUTH MEETING, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Maurits Geerlings · Plymouth Meeting, PADirectorMatthew Callahan · Plymouth Meeting, PAExec · DirectorJoseph F. Lovett · Baton Rouge, LADirectorNathan Morris · Provo, UTDirectorJonathan Ord · Provo, UTExec · DirectorJohn Johnson · Sacramento, CADirectorBrian Hubbard · Bedford, MADirectorJason Y. Zhang · Plymouth Meeting, PADirectorGreg Bell · TAMPA, FLDirectorPaul Labarre · TAMPA, FLExec · DirectorJohn Johnson · Andover, MADirectorJoseph F. Lovett · Baton Rouge, LADirectorBrian Hubbard · Bedford, MADirectorJason Y. Zhang · Plymouth Meeting, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗